Cargando…

High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors

Overlap in morphologic features between malignant and benign myogenic tumors, such as leiomyosarcoma (LMS) vs. leiomyoma as well as rhabdomyosarcoma (RMS) vs. rhabdomyoma, often makes differential diagnosis difficult and challenging. Here the expressions of Enhancer of Zeste Homolog 2 (EZH2), Suppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ning, Zeng, Zhi, Li, Shaobo, Wang, Fei, Huang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098067/ https://www.ncbi.nlm.nih.gov/pubmed/30120321 http://dx.doi.org/10.1038/s41598-018-30648-7

Ejemplares similares

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2012)

EZH2 is a sensitive marker of malignancy in salivary gland tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2015)

Differentially Expressed Proteins in Malignant and Benign Adrenocortical Tumors
por: Kjellin, Hanna, et al.
Publicado: (2014)

Exploring high-resolution chromatin interaction changes and functional enhancers of myogenic marker genes during myogenic differentiation
por: Long, Keren, et al.
Publicado: (2022)

Contrast-Enhanced Ultrasonography in Differential Diagnosis of Benign and Malignant Ovarian Tumors
por: Qiao, Jing-Jing, et al.
Publicado: (2015)

Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease
por: Lucarotti, M. E., et al.
Publicado: (1991)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers
por: Gomes, Tiago Augusto, et al.
Publicado: (2020)

CD73 a novel marker for the diagnosis of benign and malignant salivary gland tumors
por: Ranjbar, Mohammad-Ali, et al.
Publicado: (2019)

CT diagnosis and differentiation of benign and malignant varieties of solitary fibrous tumor of the pleura
por: You, Xiaofang, et al.
Publicado: (2017)

Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis
por: Cao, Shaobo, et al.
Publicado: (2016)

Multiphasic CT-Based Radiomics Analysis for the Differentiation of Benign and Malignant Parotid Tumors
por: Yu, Qiang, et al.
Publicado: (2022)

Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
por: Braunschweig, Till, et al.
Publicado: (2015)

The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
por: Dolgun, Zehra Nihal, et al.
Publicado: (2017)

Magnetic resonance diffusion kurtosis imaging in differential diagnosis of benign and malignant renal tumors
por: Fu, Jianxiong, et al.
Publicado: (2021)

Sonoelastography for differential diagnosis between malignant and benign parotid lesions: a meta-analysis
por: Zhang, Yun-Fei, et al.
Publicado: (2018)

How to Differentiate Benign from Malignant Adrenocortical Tumors?
por: Viëtor, Charlotte L., et al.
Publicado: (2021)

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
por: Wojtas, Bartosz, et al.
Publicado: (2017)

Application of Sonoelastography in Differential Diagnosis of Benign and Malignant Thyroid Nodules
por: Esfahanian, Fatemeh, et al.
Publicado: (2016)

Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
por: Liu, Jun, et al.
Publicado: (2022)

Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors
por: Li, Bo, et al.
Publicado: (2017)

Elastography for the differential diagnosis of malignant versus benign testicular lesions: a meta-analysis
por: Lin, Ziwei, et al.
Publicado: (2021)

Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms
por: Liu, Jiang, et al.
Publicado: (2022)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Study on the Effect of MRI in the Diagnosis of Benign and Malignant Thoracic Tumors
por: Li, Yan, et al.
Publicado: (2021)

Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors
por: Asanuma, Kunihiro, et al.
Publicado: (2021)

Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast
por: Li, Xiaoguang, et al.
Publicado: (2021)

Post-hypoxic myoclonus: Differentiating benign and malignant etiologies in diagnosis and prognosis
por: Freund, Brin, et al.
Publicado: (2017)

Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland
por: Bankir, Mehmet, et al.
Publicado: (2020)

Differential Diagnosis of Benign and Malignant Intraductal Papillary Mucinous Tumors of the Pancreas: MR Cholangiopancreatography and MR Angiography
por: Choi, Byung Se, et al.
Publicado: (2003)

Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors
por: Yun, Tae Hui, et al.
Publicado: (2022)

Report of two primary renal tumors with myxoid features. Differential diagnosis between benign and malignant entities
por: Fioravanzo, Adele, et al.
Publicado: (2021)

Diagnostic performance of elastosonography in the differential diagnosis of benign and malignant salivary gland tumors: A meta-analysis
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Clinical value of quantitative analysis of contrast-enhanced ultrasonography in the differential diagnosis of benign and malignant pelvic tumors
por: Fan, Qiyun, et al.
Publicado: (2023)

Fra-1 Expression in Malignant and Benign Thyroid Tumor
por: Kim, Yong-Hyun, et al.
Publicado: (2001)

Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
por: Andisheh–Tadbir, Azadeh, et al.
Publicado: (2019)

The role of histogram analysis in diffusion-weighted imaging in the differential diagnosis of benign and malignant breast lesions
por: Jin, Ya-Nan, et al.
Publicado: (2020)

Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors
por: Shlensky, David, et al.
Publicado: (2015)

The Expression of Snail, Galectin-3, and IGF1R in the Differential Diagnosis of Benign and Malignant Pheochromocytoma and Paraganglioma
por: Deng, Liling, et al.
Publicado: (2020)

Differential diagnosis of benign and malignant patchy ground-glass opacity by thin-section computed tomography
por: Liang, Zhang-rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ttka3d3t6kbeb8gm1plc31u35